National Council - Anna Cameron

Anna worked for Sanofi as the Market Access and Pricing Team Lead for Sarclisa, a treatment for Multiple Myeloma. from March of 2020 until her retirement in July 2024.

Anna has over 30 years of diverse commercial experience which spans global and US value and access, Pricing, US managed markets, marketing, product development and sales across the entire product life cycle of pharmaceutical and vaccine businesses.

Prior to joining Sanofi,  Anna worked at a variety of pharmaceutical companies, including but not limited to, GSK as the Global Market Access Franchise Partner leading the development of Market Access and pricing strategies for pre-commercial Oncology/Hematology assets resulting in Research & Development and commercial prioritization of Immunotherapy (IO), Epigenetic, and cell therapy assets.

While at BMS, Anna leveraged Global Market Access, Value and Pricing Strategies to drive coverage and reimbursement for Empliciti and Eliquis before departing to consulting. In this latter role, Anna focused on commercial, global market access and US Managed Market strategies in Oncology and Hematology.

Anna spent 23 years at Merck where she held several positions with increasing responsibility which included US New Product Development, negotiating US contracts with high control Managed Care Organizations, leading US Marketing team for CV products and launching oncology supportive care product Emend.

Anna has a BS in Medical Technology from the Rochester Institute of Technology (RIT) and MBA in Health Care Administration from Temple’s Fox School of Business